Hope Paige Medical launches TextID medical jewelry
WEST CONSHOHOCKEN, Pa. — Hope Paige Medical has introduced a new line of short message, service-enabled medical jewelry that is designed to quickly provide patients’ medical information via text message.
TextID uses SMS technology to relay life-saving information about a patient, Hope Paige Medical said. How it works: emergency medical personnel will be able to access a patient’s self-created emergency profile — which can be created online for $12 for the first year of membership (and $10 each year thereafter) — which provides detailed medical information, such as current medications, emergency contacts, etc., which can be accessed by text messaging their unique personal identification number, which is engraved on each patients’ customized medical ID jewelry, to 5-10-20.
Users of TextID medical jewelry can create their personal medical profile in minutes, which can include up to 10 emergency contacts, and can be updated at any time from any computer or smartphone at no additional charge, the company said.
TextID is powered by ICEdot, an emergency identification and notification service that enables people to store their medical and personal information in a secure online account.
"We are honored to be partnering with ICEdot to provide life-saving information to people that need it," Hope Paige Medical president Shelly Fisher said. "An individual’s information will be conveniently delivered in a text message to any cell phone. TextID is available on all major mobile phone networks. It’s perfect for anyone with a medical condition, people engaged in active lifestyles, children or elderly who wander, and those unable to effectively communicate. And because TextID makes it easy to notify emergency contacts as well as access medical information, it provides peace of mind to anyone seeking to protect their loved ones, whether or not they have a medical condition."
Implus acquired by Trilantic Capital; foot care co. poised for growth
NEW YORK — Trilantic Capital Partners, a global private equity firm, on Tuesday announced that it has partnered with management to acquire Implus, a leader in the footwear, outdoor and fitness accessories markets. Financial terms of the transaction were not disclosed.
Trilantic will partner with CEO Seth Richards and president Todd Vore to provide capital to allow the company to execute on its key growth initiatives. "Trilantic is a partner who will help us expand across business lines and in new markets, both in the [United States] and overseas, where we see tremendous opportunity," Richards said. "Trilantic has proven to be a successful partner in helping the management teams of middle-market businesses grow organically and through acquisitions. We look forward to a successful partnership."
Implus designs, markets and distributes branded consumer accessories, including insoles, shoe care products, socks, sports monitors, seasonal items and fitness products. The company supplies its products to specialty retailers and mass market chains in 70 countries across the United States, Europe and Asia.
"Implus has a strong competitive position with a proven track record of growth through innovation, customer expansion and strategic acquisition," noted Charlie Moore, partner at Trilantic.
ProPhase launches Cold-Eeze oral spray
DOYLESTOWN, Pa. — ProPhase Labs on Tuesday launched the Cold-Eeze oral spray, which is formulated with zinc gluconate to help reduce the severity and duration of the common cold.
"Our Cold-Eeze oral spray is a new opportunity to provide relief to our consumers in a new delivery system," stated Ted Karkus, chairman and CEO of ProPhase. "Our lozenges have always been a leader in the over-the-counter cough-and-cold category, and we saw Cold-Eeze oral spray as the logical next step in offering our consumers variety and alternatives to the traditional lozenge to help them reduce the severity and duration of their colds."
Two sprays offer the same amount of cold remedy (active ingredient zinc gluconate) as one Cold-Eeze lozenge, the company stated.
Available in cherry and mint flavors, each 13.3-mg bottle contains at least 45 doses.